Pulmonary complications

Tarek Eid, Alan Barker

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

After hematopoietic stem cell transplant (HSCT), up to 60% of patients develop pulmonary complications. In spite of antibacterial, antiviral, and antifungal prophylaxis, reduced host defenses render the HSCT patient vulnerable to pulmonary and other infections in the early weeks and even months post-transplantation. This chapter will suggest an integrative approach followed by a description of the most common pulmonary syndromes seen in HSCT patients, including diffuse alveolar hemorrhage (DAH), idiopathic pneumonia syndrome (IPS), bronchiolitis obliterans syndrome (BO or BOS), and cryptogenic organizing pneumonia (COP).

Original languageEnglish (US)
Title of host publicationBlood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care
PublisherSpringer New York
Pages233-244
Number of pages12
ISBN (Print)9781441975058
DOIs
StatePublished - 2011

Fingerprint

Hematopoietic Stem Cells
Transplants
Lung
Cryptogenic Organizing Pneumonia
Bronchiolitis Obliterans
Antiviral Agents
Pneumonia
Transplantation
Hemorrhage
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Eid, T., & Barker, A. (2011). Pulmonary complications. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care (pp. 233-244). Springer New York. https://doi.org/10.1007/978-1-4419-7506-5_19

Pulmonary complications. / Eid, Tarek; Barker, Alan.

Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. p. 233-244.

Research output: Chapter in Book/Report/Conference proceedingChapter

Eid, T & Barker, A 2011, Pulmonary complications. in Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, pp. 233-244. https://doi.org/10.1007/978-1-4419-7506-5_19
Eid T, Barker A. Pulmonary complications. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York. 2011. p. 233-244 https://doi.org/10.1007/978-1-4419-7506-5_19
Eid, Tarek ; Barker, Alan. / Pulmonary complications. Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. pp. 233-244
@inbook{8b7e04da048c4148b49efe30f5cf9324,
title = "Pulmonary complications",
abstract = "After hematopoietic stem cell transplant (HSCT), up to 60{\%} of patients develop pulmonary complications. In spite of antibacterial, antiviral, and antifungal prophylaxis, reduced host defenses render the HSCT patient vulnerable to pulmonary and other infections in the early weeks and even months post-transplantation. This chapter will suggest an integrative approach followed by a description of the most common pulmonary syndromes seen in HSCT patients, including diffuse alveolar hemorrhage (DAH), idiopathic pneumonia syndrome (IPS), bronchiolitis obliterans syndrome (BO or BOS), and cryptogenic organizing pneumonia (COP).",
author = "Tarek Eid and Alan Barker",
year = "2011",
doi = "10.1007/978-1-4419-7506-5_19",
language = "English (US)",
isbn = "9781441975058",
pages = "233--244",
booktitle = "Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care",
publisher = "Springer New York",

}

TY - CHAP

T1 - Pulmonary complications

AU - Eid, Tarek

AU - Barker, Alan

PY - 2011

Y1 - 2011

N2 - After hematopoietic stem cell transplant (HSCT), up to 60% of patients develop pulmonary complications. In spite of antibacterial, antiviral, and antifungal prophylaxis, reduced host defenses render the HSCT patient vulnerable to pulmonary and other infections in the early weeks and even months post-transplantation. This chapter will suggest an integrative approach followed by a description of the most common pulmonary syndromes seen in HSCT patients, including diffuse alveolar hemorrhage (DAH), idiopathic pneumonia syndrome (IPS), bronchiolitis obliterans syndrome (BO or BOS), and cryptogenic organizing pneumonia (COP).

AB - After hematopoietic stem cell transplant (HSCT), up to 60% of patients develop pulmonary complications. In spite of antibacterial, antiviral, and antifungal prophylaxis, reduced host defenses render the HSCT patient vulnerable to pulmonary and other infections in the early weeks and even months post-transplantation. This chapter will suggest an integrative approach followed by a description of the most common pulmonary syndromes seen in HSCT patients, including diffuse alveolar hemorrhage (DAH), idiopathic pneumonia syndrome (IPS), bronchiolitis obliterans syndrome (BO or BOS), and cryptogenic organizing pneumonia (COP).

UR - http://www.scopus.com/inward/record.url?scp=84892195731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892195731&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-7506-5_19

DO - 10.1007/978-1-4419-7506-5_19

M3 - Chapter

AN - SCOPUS:84892195731

SN - 9781441975058

SP - 233

EP - 244

BT - Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care

PB - Springer New York

ER -